Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Latest filing published 23 Jul 2021 for ALEXION PHARMACEUTICALS, INC..
Insider track record
Disclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Daniel Bazarko: trading record in brief
All filings by Daniel Bazarko on record concern Alexion Pharmaceuticals Inc, in the capacity of senior executive. Over a trading history stretching from 14 February 2019 to 21 July 2021, the count stands at 23 filings.
Sales make up the whole of the open-market record (4 sales, €3.3M). Other entries cover 16 share grants and 2 option exercises.
Most recently, on 23 July 2021, the filings show a transaction in Alexion Pharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Daniel Bazarko
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
60,207 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000067:0
11,060 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000055:0
2 of 2 declarations
